The conventional chemotherapeutics could not be traced in vivo and provide timely feedback on the clinical effectiveness of drugs. In this study, poly(L-γ-glutamyl-
glutamine)-
paclitaxel (
PGG-PTX), as a model
polymer, was chemically conjugated with
Gd-DTPA (Gd-diethylenetriaminepentaacetic
acid), a T1-contrast agent of MRI, to prepare a
Gd-DTPA-conjugated
PGG-PTX (
PGG-PTX-
DTPA-Gd) delivery system used for
tumor theranostics.
PGG-PTX-
DTPA-Gd can be self-assembled to NPs in water with a z-average hydrodynamic diameter about 35.9 nm. The 3 T MRI results confirmed that the relaxivity of
PGG-PTX-
DTPA-Gd NPs (r1 = 18.98 mM-1S-1) was increased nearly 4.9 times compared with that of free
Gd-DTPA (r1 = 3.87 mM-1S-1). The in vivo fluorescence imaging results showed that
PGG-PTX-
DTPA-Gd NPs could be accumulated in the
tumor tissue of NCI-H460
lung cancer animal model by EPR effect, which was similar to
PGG-PTX NPs. The MRI results showed that compared with free
Gd-DTPA,
PGG-PTX-
DTPA-Gd NPs showed significantly enhanced and prolonged signal intensity in
tumor tissue, which should be attributed to the increased relaxivity and
tumor accumulation.
PGG-PTX-
DTPA-Gd NPs also showed effective antitumor effect in vivo. These results indicated that
PGG-PTX-
DTPA-Gd NPs are an effective delivery system for
tumor theranostics, and should have a potential value in personalized treatment of
tumor.